SERMON CHARLES (General Counsel) sold 12.4% of their position (30.93K shares) of MEREO BIOPHARMA GROUP PLC on the open market
Open‑market sale worth $133.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/16/2024ACC: 0000950170-24-106972
Officer· General Counsel
Since Feb 2026
-30.93K
Net shares
Net seller
$133.1K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
30.93K disposed
Non-Derivative Transactions2
American Depositary Shares representing Ordinary Shares
Direct
Shares
−9.98K
Price / share
$4.47
Trade value
$44.64K
% of position
4.0%
9/12/2024
249.99K→240.01K
American Depositary Shares representing Ordinary Shares
Direct
Shares
−20.95K
Price / share
$4.22
Trade value
$88.41K
% of position
8.7%
9/13/2024
240.01K→219.06K
Total
Net shares
−30.93K
Net value
-$133.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares representing Ordinary Shares Direct | 9/12/2024 | S · Sale | −9.98K | $4.47 | $44.64K | 4.0% | 249.99K | 240.01K |
| American Depositary Shares representing Ordinary Shares Direct | 9/13/2024 | S · Sale | −20.95K | $4.22 | $88.41K | 8.7% | 240.01K | 219.06K |
| Total | −30.93K | -$133.05K | ||||||
Derivative Transactions0
No derivative transactions reported